Skip to Main Content

Paper Details

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.
Contemp Clin Trials
9
2022
Author NameAffiliation
Graham M SnyderUniversity of Pittsburgh School of Medicine
Christopher W SeymourClinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine
Donald M YealyUniversity of Pittsburgh School of Medicine
David T HuangUniversity of Pittsburgh School of Medicine, USA Clinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center
Derek C AngusClinical Research Investigation and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine
  • 1 - 5

Datasets